Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.
Records under this name other than the patents Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Showing 1 to 3 of 3 · Back to Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,331,047 | Synthesis for 3-Bromo-5-(2-Ethylimidazo[1, 2-Alpha]PYRIDINE- 3-Carbonyl)-2-Hydroxybenzonitrile Formerly held In force · High confidence | In force | High confidence | |
| US 9,802,907 | 2-aryl selenazole compound and pharmaceutical composition thereof Lapsed on the fee record Ended Oct 31, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 31, 2025 | From the USPTO record |
| US 10,875,865 | URAT1 Inhibitor and Use Thereof Surrendered on reissue Surrendered on reissue Aug 20, 2024 · High confidence | Surrendered on reissue | Surrendered on reissue Aug 20, 2024 | High confidence |